NewsVandana Singh
Aptevo Therapeutics
APVO · NASDAQ
$1.62−$0.005 (−0.31%)TodayMarket closed ·
Prev close $1.62
Latest news
- Press releaseACCESS Newswire
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseACCESS Newswire
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
- Press releaseACCESS Newswire
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
- Press releaseACCESS Newswire
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
- Press releaseACCESS Newswire
Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
- Press releaseACCESS Newswire
Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors
- Press releaseACCESS Newswire
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
- Press releaseACCESS Newswire
Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing
- Press releaseACCESS Newswire
Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
10 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsAlex Perry
What's Going On With Aptevo Therapeutics Stock Today?
- NewsAvi Kapoor
US Stocks Mixed; Biohaven Shares Fall
- NewsAvi Kapoor
Gold Falls Over 1%; Darden Posts Downbeat Earnings
- NewsAvi Kapoor
Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge
- News
Market-Moving News for September 18th
- NewsAvi Kapoor
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
- News
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
- NewsAvi Kapoor
Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Crude Oil Moves Higher; US Weekly Jobless Claims Decline
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Dow Surges 150 Points; Korn Ferry Earnings Top Views
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
11 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- NewsVandana Singh
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment
- NewsAvi Kapoor
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
- NewsAvi Kapoor
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.